These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 24421042)
1. Evidence for strain-specific immunity in patients treated for early lyme disease. Khatchikian CE; Nadelman RB; Nowakowski J; Schwartz I; Wormser GP; Brisson D Infect Immun; 2014 Apr; 82(4):1408-13. PubMed ID: 24421042 [TBL] [Abstract][Full Text] [Related]
2. Public health impact of strain specific immunity to Borrelia burgdorferi. Khatchikian CE; Nadelman RB; Nowakowski J; Schwartz I; Levy MZ; Brisson D; Wormser GP BMC Infect Dis; 2015 Oct; 15():472. PubMed ID: 26503011 [TBL] [Abstract][Full Text] [Related]
3. The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous. Khatchikian CE; Nadelman RB; Nowakowski J; Schwartz I; Wormser GP; Brisson D Diagn Microbiol Infect Dis; 2017 Dec; 89(4):288-293. PubMed ID: 29021088 [TBL] [Abstract][Full Text] [Related]
4. Age-Related Differential Stimulation of Immune Response by Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N Front Immunol; 2018; 9():2891. PubMed ID: 30619263 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of Borrelia burgdorferi genostrains among patients with Lyme disease]. Biesiada G; Czepiel J; Salamon D; Garlicki A; Dziubek A; Maziarz B; Mach T Przegl Lek; 2009; 66(9):511-2. PubMed ID: 21033412 [TBL] [Abstract][Full Text] [Related]
6. Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection. Elsner RA; Hastey CJ; Olsen KJ; Baumgarth N PLoS Pathog; 2015 Jul; 11(7):e1004976. PubMed ID: 26136236 [TBL] [Abstract][Full Text] [Related]
7. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia. Malkiel S; Kuhlow CJ; Mena P; Benach JL J Immunol; 2009 Jan; 182(1):498-506. PubMed ID: 19109181 [TBL] [Abstract][Full Text] [Related]
8. The role of host immune cells and Borrelia burgdorferi antigens in the etiology of Lyme disease. Verhaegh D; Joosten LAB; Oosting M Eur Cytokine Netw; 2017 Jun; 28(2):70-84. PubMed ID: 28840838 [TBL] [Abstract][Full Text] [Related]
9. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk for and patients with Lyme disease. Bunikis J; Olsén B; Westman G; Bergstroöm S J Clin Microbiol; 1995 Jun; 33(6):1473-8. PubMed ID: 7650170 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of a Putnik R; Zhou J; Irnov I; Garner E; Liu M; Bersch KL; Jacobs-Wagner C; Grimes CL Molecules; 2024 Jul; 29(14):. PubMed ID: 39064876 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Lyme Disease in the United States and Europe. Marques AR; Strle F; Wormser GP Emerg Infect Dis; 2021 Aug; 27(8):2017-2024. PubMed ID: 34286689 [TBL] [Abstract][Full Text] [Related]
12. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Steere AC; Drouin EE; Glickstein LJ Clin Infect Dis; 2011 Feb; 52 Suppl 3(Suppl 3):s259-65. PubMed ID: 21217173 [TBL] [Abstract][Full Text] [Related]
13. Update on persistent symptoms associated with Lyme disease. Oliveira CR; Shapiro ED Curr Opin Pediatr; 2015 Feb; 27(1):100-4. PubMed ID: 25490690 [TBL] [Abstract][Full Text] [Related]